Literature DB >> 7878750

Primary kidney tumors before and after renal transplantation.

I Penn1.   

Abstract

Three groups of patients were reviewed. Primary carcinomas were found in donors kidneys of 47 recipients. In 30 instances a tumor was present at harvesting. When a neoplasm was removed immediately pretransplantation or early posttransplantation there were no recurrences in 14 recipients. In another two instances, a tumor was not removed or was incompletely excised pretransplantation and both recipients died of metastases. Fourteen other patients received kidneys from donors in whom the opposite kidney had a malignancy. Thirteen remained tumor-free and one had allograft nephrectomy for rejection 3 months posttransplantation when a carcinoma was found. In 17 recipients an allograft neoplasm was not recognized at harvesting. In 9 it was discovered at graft nephrectomy an average of 3 months posttransplantation. In a tenth patient a hypoechogenic area, found on routine posttransplant ultrasonography, progressively increased in size and proved to be malignant. Another 7 patients developed metastases from renal carcinomas an average of 12 months posttransplantation. Preexisting carcinomas were found in 350 recipients. Seventy-one patients with incidentally discovered tumors had no recurrences no matter when nephrectomy was performed in relationship to transplantation. Of 279 patients with symptomatic renal tumors, 70 (25%) had recurrences, 63% of which occurred in patients treated < or = 2 years pretransplantation. De novo cancers were found posttransplantation in 256 recipients. Renal carcinomas were 4.6% of posttransplant cancers compared with 3% of tumors in the general population. In 222 patients their own diseased kidneys were involved, in 24 tumors occurred in the allograft, and in 10 cases the site was not stated. Development of neoplasia seemed to be related not to the immunosuppressive therapy but to the underlying cause of renal failure, especially analgesic nephropathy. A disproportionate number of carcinomas (15%) involved the renal pelvis, most likely because of prior analgesic abuse.

Entities:  

Mesh:

Year:  1995        PMID: 7878750

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  32 in total

1.  Immune responses against islet allografts during tapering of immunosuppression--a pilot study in 5 subjects.

Authors:  V A L Huurman; C R van der Torren; P Gillard; R Hilbrands; E P M W van der Meer-Prins; G Duinkerken; F K Gorus; F H J Claas; B Keymeulen; D L Roelen; D G Pipeleers; B O Roep
Journal:  Clin Exp Immunol       Date:  2012-08       Impact factor: 4.330

2.  Urothelial carcinoma of the allograft kidney developed in a renal transplant patient.

Authors:  Mehmet İlker Gökçe; Akın Fırat Kocaay; Serkan Aktürk; Acar Tüzüner
Journal:  Turk J Urol       Date:  2016-09

3.  Guidelines for the assessment and acceptance of potential brain-dead organ donors.

Authors:  Glauco Adrieno Westphal; Valter Duro Garcia; Rafael Lisboa de Souza; Cristiano Augusto Franke; Kalinca Daberkow Vieira; Viviane Renata Zaclikevis Birckholz; Miriam Cristine Machado; Eliana Régia Barbosa de Almeida; Fernando Osni Machado; Luiz Antônio da Costa Sardinha; Raquel Wanzuita; Carlos Eduardo Soares Silvado; Gerson Costa; Vera Braatz; Milton Caldeira Filho; Rodrigo Furtado; Luana Alves Tannous; André Gustavo Neves de Albuquerque; Edson Abdala
Journal:  Rev Bras Ter Intensiva       Date:  2016-09

4.  Living-donor transplantation after excision of unrecognized renal cancer diagnosed after transplant.

Authors:  Marta Melgosa Hijosa; Angel Alonso Melgar; Ma José Martínez Urrutia; Carmen García Meseguer; Enrique Jaureguizar Monereo; Mercedes Navarro Torres
Journal:  Pediatr Nephrol       Date:  2012-07-18       Impact factor: 3.714

5.  Two papillary renal cell carcinomas of different origin following renal transplantation (Case report).

Authors:  Hans-Ulrich Gerth; Michele Pohlen; Nils-Heinrich Thoennissen; Barbara Suwelack; Hermann-Josef Pavenstädt; Stefan Störkel; Mahmoud Abbas; Tilmann Spieker; Gerold Thölking
Journal:  Oncol Lett       Date:  2012-05-04       Impact factor: 2.967

6.  Partial nephrectomy used to treat renal cell carcinoma arising in a live donor transplant kidney.

Authors:  G W A Lamb; G M Baxter; R S C Rodger; M Aitchison
Journal:  Urol Res       Date:  2004-05

7.  Transitional cell carcinoma in renal transplant recipients.

Authors:  Yu-Lin Kao; Yen-Chuan Ou; Chi-Rei Yang; Hao-Chung Ho; Chung-Kuang Su; Kuo-Hsiung Shu
Journal:  World J Surg       Date:  2003-06-06       Impact factor: 3.352

8.  Detection and management of renal cell carcinoma in the renal allograft.

Authors:  Gyula Végső; Éva Toronyi; Pál Ákos Deák; Attila Doros; Róbert Miklós Langer
Journal:  Int Urol Nephrol       Date:  2012-09-01       Impact factor: 2.370

Review 9.  Transplantation of kidneys with tumors.

Authors:  Giovanni M Frascà; Antonia D'Errico; Deborah Malvi; Camillo Porta; Laura Cosmai; Matteo Santoni; Silvio Sandrini; Chiara Salviani; Maurizio Gallieni; Emilio Balestra
Journal:  J Nephrol       Date:  2015-11-20       Impact factor: 3.902

10.  Incidental solid renal mass in a cadaveric donor kidney.

Authors:  R M Meyyappan; T Rajaraman; D Senthil
Journal:  Indian J Urol       Date:  2012-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.